Cargando…

The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure

BACKGROUND: Pre-evaluation of endogenous immunoglobulin levels is a potential strategy to improve the results of intravenous immunoglobulins in sepsis, but more work has to be done to identify those patients who could benefit the most from this treatment. The objective of this study was to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin-Loeches, Ignacio, Muriel-Bombín, Arturo, Ferrer, Ricard, Artigas, Antonio, Sole-Violan, Jordi, Lorente, Leonardo, Andaluz-Ojeda, David, Prina-Mello, Adriele, Herrán-Monge, Ruben, Suberviola, Borja, Rodriguez-Fernandez, Ana, Merino, Pedro, Loza, Ana M., Garcia-Olivares, Pablo, Anton, Eduardo, Tamayo, Eduardo, Trapiello, Wysali, Blanco, Jesús, Bermejo-Martin, Jesús F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Paris 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399013/
https://www.ncbi.nlm.nih.gov/pubmed/28429310
http://dx.doi.org/10.1186/s13613-017-0268-3
_version_ 1783230552388665344
author Martin-Loeches, Ignacio
Muriel-Bombín, Arturo
Ferrer, Ricard
Artigas, Antonio
Sole-Violan, Jordi
Lorente, Leonardo
Andaluz-Ojeda, David
Prina-Mello, Adriele
Herrán-Monge, Ruben
Suberviola, Borja
Rodriguez-Fernandez, Ana
Merino, Pedro
Loza, Ana M.
Garcia-Olivares, Pablo
Anton, Eduardo
Tamayo, Eduardo
Trapiello, Wysali
Blanco, Jesús
Bermejo-Martin, Jesús F.
author_facet Martin-Loeches, Ignacio
Muriel-Bombín, Arturo
Ferrer, Ricard
Artigas, Antonio
Sole-Violan, Jordi
Lorente, Leonardo
Andaluz-Ojeda, David
Prina-Mello, Adriele
Herrán-Monge, Ruben
Suberviola, Borja
Rodriguez-Fernandez, Ana
Merino, Pedro
Loza, Ana M.
Garcia-Olivares, Pablo
Anton, Eduardo
Tamayo, Eduardo
Trapiello, Wysali
Blanco, Jesús
Bermejo-Martin, Jesús F.
author_sort Martin-Loeches, Ignacio
collection PubMed
description BACKGROUND: Pre-evaluation of endogenous immunoglobulin levels is a potential strategy to improve the results of intravenous immunoglobulins in sepsis, but more work has to be done to identify those patients who could benefit the most from this treatment. The objective of this study was to evaluate the impact of endogenous immunoglobulins on the mortality risk in sepsis depending on disease severity. METHODS: This was a retrospective observational study including 278 patients admitted to the ICU with sepsis fulfilling the SEPSIS-3 criteria, coming from the Spanish GRECIA and ABISS-EDUSEPSIS cohorts. Patients were distributed into two groups depending on their Sequential Organ Failure Assessment score at ICU admission (SOFA < 8, n = 122 and SOFA ≥ 8, n = 156), and the association between immunoglobulin levels at ICU admission with mortality was studied in each group by Kaplan–Meier and multivariate logistic regression analysis. RESULTS: ICU/hospital mortality in the SOFA < 8 group was 14.8/23.0%, compared to 30.1/35.3% in the SOFA ≥ 8 group. In the group with SOFA < 8, the simultaneous presence of total IgG < 407 mg/dl, IgM < 43 mg/dl and IgA < 219 mg/dl was associated with a reduction in the survival mean time of 6.6 days in the first 28 days and was a robust predictor of mortality risk either during the acute or during the post-acute phase of the disease (OR for ICU mortality: 13.79; OR for hospital mortality: 7.98). This predictive ability remained in the absence of prior immunosuppression (OR for ICU mortality: 17.53; OR for hospital mortality: 5.63). Total IgG < 407 mg/dl or IgG1 < 332 mg/dl was also an independent predictor of ICU mortality in this group. In contrast, in the SOFA ≥ 8 group, we found no immunoglobulin thresholds associated with neither ICU nor hospital mortality. CONCLUSIONS: Endogenous immunoglobulin levels may have a different impact on the mortality risk of sepsis patients based on their severity. In patients with moderate organ failure, the simultaneous presence of low levels of IgG, IgA and IgM was a consistent predictor of both acute and post-acute mortalities. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13613-017-0268-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5399013
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Paris
record_format MEDLINE/PubMed
spelling pubmed-53990132017-05-08 The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure Martin-Loeches, Ignacio Muriel-Bombín, Arturo Ferrer, Ricard Artigas, Antonio Sole-Violan, Jordi Lorente, Leonardo Andaluz-Ojeda, David Prina-Mello, Adriele Herrán-Monge, Ruben Suberviola, Borja Rodriguez-Fernandez, Ana Merino, Pedro Loza, Ana M. Garcia-Olivares, Pablo Anton, Eduardo Tamayo, Eduardo Trapiello, Wysali Blanco, Jesús Bermejo-Martin, Jesús F. Ann Intensive Care Research BACKGROUND: Pre-evaluation of endogenous immunoglobulin levels is a potential strategy to improve the results of intravenous immunoglobulins in sepsis, but more work has to be done to identify those patients who could benefit the most from this treatment. The objective of this study was to evaluate the impact of endogenous immunoglobulins on the mortality risk in sepsis depending on disease severity. METHODS: This was a retrospective observational study including 278 patients admitted to the ICU with sepsis fulfilling the SEPSIS-3 criteria, coming from the Spanish GRECIA and ABISS-EDUSEPSIS cohorts. Patients were distributed into two groups depending on their Sequential Organ Failure Assessment score at ICU admission (SOFA < 8, n = 122 and SOFA ≥ 8, n = 156), and the association between immunoglobulin levels at ICU admission with mortality was studied in each group by Kaplan–Meier and multivariate logistic regression analysis. RESULTS: ICU/hospital mortality in the SOFA < 8 group was 14.8/23.0%, compared to 30.1/35.3% in the SOFA ≥ 8 group. In the group with SOFA < 8, the simultaneous presence of total IgG < 407 mg/dl, IgM < 43 mg/dl and IgA < 219 mg/dl was associated with a reduction in the survival mean time of 6.6 days in the first 28 days and was a robust predictor of mortality risk either during the acute or during the post-acute phase of the disease (OR for ICU mortality: 13.79; OR for hospital mortality: 7.98). This predictive ability remained in the absence of prior immunosuppression (OR for ICU mortality: 17.53; OR for hospital mortality: 5.63). Total IgG < 407 mg/dl or IgG1 < 332 mg/dl was also an independent predictor of ICU mortality in this group. In contrast, in the SOFA ≥ 8 group, we found no immunoglobulin thresholds associated with neither ICU nor hospital mortality. CONCLUSIONS: Endogenous immunoglobulin levels may have a different impact on the mortality risk of sepsis patients based on their severity. In patients with moderate organ failure, the simultaneous presence of low levels of IgG, IgA and IgM was a consistent predictor of both acute and post-acute mortalities. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13613-017-0268-3) contains supplementary material, which is available to authorized users. Springer Paris 2017-04-20 /pmc/articles/PMC5399013/ /pubmed/28429310 http://dx.doi.org/10.1186/s13613-017-0268-3 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Martin-Loeches, Ignacio
Muriel-Bombín, Arturo
Ferrer, Ricard
Artigas, Antonio
Sole-Violan, Jordi
Lorente, Leonardo
Andaluz-Ojeda, David
Prina-Mello, Adriele
Herrán-Monge, Ruben
Suberviola, Borja
Rodriguez-Fernandez, Ana
Merino, Pedro
Loza, Ana M.
Garcia-Olivares, Pablo
Anton, Eduardo
Tamayo, Eduardo
Trapiello, Wysali
Blanco, Jesús
Bermejo-Martin, Jesús F.
The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure
title The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure
title_full The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure
title_fullStr The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure
title_full_unstemmed The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure
title_short The protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure
title_sort protective association of endogenous immunoglobulins against sepsis mortality is restricted to patients with moderate organ failure
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399013/
https://www.ncbi.nlm.nih.gov/pubmed/28429310
http://dx.doi.org/10.1186/s13613-017-0268-3
work_keys_str_mv AT martinloechesignacio theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT murielbombinarturo theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT ferrerricard theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT artigasantonio theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT soleviolanjordi theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT lorenteleonardo theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT andaluzojedadavid theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT prinamelloadriele theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT herranmongeruben theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT suberviolaborja theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT rodriguezfernandezana theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT merinopedro theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT lozaanam theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT garciaolivarespablo theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT antoneduardo theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT tamayoeduardo theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT trapiellowysali theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT blancojesus theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT bermejomartinjesusf theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT theprotectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT martinloechesignacio protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT murielbombinarturo protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT ferrerricard protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT artigasantonio protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT soleviolanjordi protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT lorenteleonardo protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT andaluzojedadavid protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT prinamelloadriele protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT herranmongeruben protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT suberviolaborja protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT rodriguezfernandezana protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT merinopedro protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT lozaanam protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT garciaolivarespablo protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT antoneduardo protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT tamayoeduardo protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT trapiellowysali protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT blancojesus protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT bermejomartinjesusf protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure
AT protectiveassociationofendogenousimmunoglobulinsagainstsepsismortalityisrestrictedtopatientswithmoderateorganfailure